Is depression in Parkinson's Disease (PD) a specific entity?

Journal of Affective Disorders

Volumn 139, Issue 2, 2012, Pages 103-112

  Even, Christian ^a,b   Weintraub, Daniel ^c,d  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Depression; Mood disorders; Parkinson's Disease

Indexed keywords

CITALOPRAM; DESIPRAMINE; ESCITALOPRAM; METHYLPHENIDATE; NORTRIPTYLINE; PAROXETINE; PLACEBO; PRAMIPEXOLE; SERTRALINE; VENLAFAXINE;

COMORBIDITY; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUICIDAL BEHAVIOR; TREATMENT RESPONSE;

COMORBIDITY; DEPRESSION; DOPAMINE; HUMANS; MALE; NEUROTRANSMITTER AGENTS; PARKINSON DISEASE; UNITED STATES;

EID: 84862149820     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.07.002     Document Type: Review

References (119)

1. Y. Agid Biochemistry of neurotransmitters in Parkinson's disease C.D. Marsden, S. Fahn, Movement Disorders 1987 Butterworth London 166 230
2. G.S. Alexopoulos, D.N. Kiosses, S.J. Choi, C.F. Murphy, and K.O. Lim Frontal white matter microstructure and treatment response of late-life depression: a preliminary study Am. J. Psychiatry 159 2002 1929 1932
3. Anonymous Treatment of depression in idiopathic Parkinson's disease Mov. Disord. 17 Suppl. 4 2002 S112 S119
4. G. Asnis Parkinson's disease, depression, and ECT: a review and case study Am. J. Psychiatry 134 1977 191 195
5. B. Ball De l'insanité de la paralysie agitante L'Encéphale 2 1882 22 32
6. P. Barone Depression and antidepressant use in Parkinson's disease: results from the PRODEST-PD study 2007
7. P. Barone, W. Poewe, S. Albrecht, C. Debieuvre, D. Massey, O. Rascol, E. Tolosa, and D. Weintraub Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial Lancet Neurol. 9 2010 573 580
8. B.P. Bejjani, P. Damier, I. Arnulf, L. Thivard, A.M. Bonnet, D. Dormont, P. Cornu, B. Pidoux, Y. Samson, and Y. Agid Transient acute depression induced by high-frequency deep-brain stimulation N. Engl. J. Med. 340 1999 1476 1480
9. K.C. Berridge, and T.E. Robinson What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Brain Res. Rev. 28 1998 309 369
10. N.I. Bohnen, D.I. Kaufer, L.S. Ivanco, B. Lopresti, R.A. Koeppe, J.G. Davis, C.A. Mathis, R.Y. Moore, and S.T. DeKosky Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study Arch. Neurol. 60 2003 1745 1748
11. A. Borta, and G.U. Hoglinger Dopamine and adult neurogenesis J. Neurochem. 100 2007 587 595
12. C. Bowden, S.C. Cheetham, S. Lowther, C.L. Katona, M.R. Crompton, and R.W. Horton Reduced dopamine turnover in the basal ganglia of depressed suicides Brain Res. 769 1997 135 140
13. R.A. Bressan, and J.A. Crippa The role of dopamine in reward and pleasure behaviour - review of data from preclinical research Acta Psychiatr. Scand. Suppl. 2005 14 21
14. R.G. Brown, B. MacCarthy, A.M. Gotham, G.J. Der, and C.D. Marsden Depression and disability in Parkinson's disease: a follow-up of 132 cases Psychol. Med. 18 1988 49 55
15. D.J. Burn Depression in Parkinson's disease Eur. J. Neurol. 9 Suppl. 3 2002 44 54
16. D.J. Burn, W. Tiangyou, L.M. Allcock, J. Davison, and P.F. Chinnery Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease Parkinsonism Relat. Disord. 12 2006 139 141
17. R. Cantello, M. Aguggia, M. Gilli, M. Delsedime, I. Chiardo Cutin, A. Riccio, and R. Mutani Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the hedonic dopamine synapse J. Neurol. Neurosurg. Psychiatry 52 1989 724 731
18. E.F. Cardoso, F.M. Maia, F. Fregni, M.L. Myczkowski, L.M. Melo, J.R. Sato, M.A. Marcolin, S.P. Rigonatti, A.C. Cruz Jr., E.R. Barbosa, and E. Amaro Jr. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus NeuroImage 47 2009 467 472
19. A. Caspi, K. Sugden, T.E. Moffitt, A. Taylor, I.W. Craig, H. Harrington, J. McClay, J. Mill, J. Martin, A. Braithwaite, and R. Poulton Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Science 301 2003 386 389
20. V. Chan-Palay, and E. Asan Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression J. Comp. Neurol. 287 1989 373 392
21. T.H. Chung, K.H. Deane, S. Ghazi-Noori, H. Rickards, and C.E. Clarke Systematic review of antidepressant therapies in Parkinson's disease Parkinsonism Relat. Disord. 10 2003 59 65
22. S.A. Cole, J.L. Woodard, J.L. Juncos, J.L. Kogos, E.A. Youngstrom, and R.L. Watts Depression and disability in Parkinson's disease J. Neuropsychiatry Clin. Neurosci. 8 1996 20 25
23. D.A. Collier, G. Stober, T. Li, A. Heils, M. Catalano, D. Di Bella, M.J. Arranz, R.M. Murray, H.P. Vallada, D. Bengel, C.R. Muller, G.W. Roberts, E. Smeraldi, G. Kirov, P. Sham, and K.P. Lesch A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders Mol. Psychiatry 1 1996 453 460
24. M.H. Corrigan, A.Q. Denahan, C.E. Wright, R.J. Ragual, and D.L. Evans Comparison of pramipexole, fluoxetine, and placebo in patients with major depression Depress. Anxiety 11 2000 58 65
25. J.L. Cummings Depression and Parkinson's disease: a review Am. J. Psychiatry 149 1992 443 454
26. D. Devos, K. Dujardin, I. Poirot, C. Moreau, O. Cottencin, P. Thomas, A. Destee, R. Bordet, and L. Defebvre Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study Mov. Disord. 23 2008 850 857
27. N.N. Dissanayaka, P.A. Silburn, J.D. O'Sullivan, and G.D. Mellick Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease Mov. Disord. 24 2009 111 115
28. M. Doder, E.A. Rabiner, N. Turjanski, A.J. Lees, and D.J. Brooks Tremor in Parkinson's disease and serotonergic dysfunction: an 11 C-WAY 100635 PET study Neurology 60 2003 601 605
29. L.E. Egede Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability Gen. Hosp. Psychiatry 29 2007 409 416
30. U. Ehrt, K. Bronnick, A.F. Leentjens, J.P. Larsen, and D. Aarsland Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease Int. J. Geriatr. Psychiatry 21 2006 252 258
31. S. Fahim, C.M. van Duijn, F.M. Baker, L. Launer, M.M. Breteler, W.J. Schudel, and A. Hofman A study of familial aggregation of depression, dementia and Parkinson's disease Eur. J. Epidemiol. 14 1998 233 238
32. J. Fang, and Q. Cheng Etiological mechanisms of post-stroke depression: a review Neurol. Res. 31 2009 904 909
33. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 1991 2283 2301
34. P.G. Frisina, V. Haroutunian, and L.S. Libow The neuropathological basis for depression in Parkinson's disease Parkinsonism Relat. Disord. 15 2009 144 148
35. A.M. Gotham, R.G. Brown, and C.D. Marsden Depression in Parkinson's disease: a quantitative and qualitative analysis J. Neurol. Neurosurg. Psychiatry 49 1986 381 389
36. E. Gould, P. Tanapat, B.S. McEwen, G. Flugge, and E. Fuchs Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress Proc. Natl. Acad. Sci. U. S. A. 95 1998 3168 3171
37. G.M. Halliday, P.C. Blumbergs, R.G. Cotton, W.W. Blessing, and L.B. Geffen Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease Brain Res. 510 1990 104 107
38. P. Hantz, G. Caradoc-Davies, T. Caradoc-Davies, M. Weatherall, and G. Dixon Depression in Parkinson's disease Am. J. Psychiatry 151 1994 1010 1014
39. S. Happe, B. Schrodl, M. Faltl, C. Muller, E. Auff, and J. Zeitlhofer Sleep disorders and depression in patients with Parkinson's disease Acta Neurol. Scand. 104 2001 275 280
40. S. Hesse, P.M. Meyer, K. Strecker, H. Barthel, F. Wegner, C. Oehlwein, I.U. Isaias, J. Schwarz, and O. Sabri Monoamine transporter availability in Parkinson's disease patients with or without depression Eur. J. Nucl. Med. Mol. Imaging 36 2009 428 435
41. G.U. Hoglinger, P. Rizk, M.P. Muriel, C. Duyckaerts, W.H. Oertel, I. Caille, and E.C. Hirsch Dopamine depletion impairs precursor cell proliferation in Parkinson disease Nat. Neurosci. 7 2004 726 735
42. L. Ishihara, and C. Brayne A systematic review of depression and mental illness preceding Parkinson's disease Acta Neurol. Scand. 113 2006 211 220
43. K. Jellinger New developments in the pathology of Parkinson's disease Adv. Neurol. 53 1990 1 16
44. F. Kanda, K. Oishi, K. Sekiguchi, A. Kuga, H. Kobessho, T. Shirafuji, M. Higuchi, and H. Ishihara Characteristics of depression in Parkinson's disease: evaluating with Zung's Self-Rating Depression Scale Parkinsonism Relat. Disord. 14 2008 19 23
45. T.R. Kearney Parkinson's disease presenting as depressive illness J. Ir. Med. Assoc. 54 1964 117 119
46. S.E. Kim, J.Y. Choi, Y.S. Choe, Y. Choi, and W.Y. Lee Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT J. Nucl. Med. 44 2003 870 876
47. V.S. Kostic, B.M. Djuricic, N. Covickovic-Sternic, L. Bumbasirevic, M. Nikolic, and B.B. Mrsulja Depression and Parkinson's disease: possible role of serotonergic mechanisms J. Neurol. 234 1987 94 96
48. V.S. Kostic, D. Lecic, M. Doder, J. Marinkovic, and S. Filipovic Prolactin and cortisol responses to fenfluramine in Parkinson's disease Biol. Psychiatry 40 1996 769 775
49. K.R. Krishnan, M. Delong, H. Kraemer, R. Carney, D. Spiegel, C. Gordon, W. McDonald, M. Dew, G. Alexopoulos, K. Buckwalter, P.D. Cohen, D. Evans, P.G. Kaufmann, J. Olin, E. Otey, and C. Wainscott Comorbidity of depression with other medical diseases in the elderly Biol. Psychiatry 52 2002 559 588
50. W. Kuhn, T. Muller, M. Gerlach, E. Sofic, G. Fuchs, N. Heye, R. Prautsch, and H. Przuntek Depression in Parkinson's disease: biogenic amines in CSF of de novo patients J. Neural Transm. 103 1996 1441 1445
51. A. Kummer, F. Cardoso, and A.L. Teixeira Suicidal ideation in Parkinson's disease CNS Spectr. 14 2009 431 436
52. A.F. Leentjens, R. Lousberg, and F.R. Verhey Markers for depression in Parkinson's disease Acta Psychiatr. Scand. 106 2002 196 201
53. A.F. Leentjens, M. Van den Akker, J.F. Metsemakers, R. Lousberg, and F.R. Verhey Higher incidence of depression preceding the onset of Parkinson's disease: a register study Mov. Disord. 18 2003 414 418
54. A.F. Leentjens, F.W. Vreeling, G.J. Luijckx, and F.R. Verhey SSRIs in the treatment of depression in Parkinson's disease Int. J. Geriatr. Psychiatry 18 2003 552 554
55. A.F. Leentjens, B. Scholtissen, F.W. Vreeling, and F.R. Verhey The serotonergic hypothesis for depression in Parkinson's disease: an experimental approach Neuropsychopharmacology 31 2006 1009 1015
56. M.R. Lemke Depressive symptoms in Parkinson's disease Eur. J. Neurol. 15 Suppl. 1 2008 21 25
57. A. Lieberman Depression in Parkinson's disease - a review Acta Neurol. Scand. 113 2006 1 8
58. J.L. Mace, R.J. Porter, J.C. Dalrymple-Alford, and T.J. Anderson The effects of acute tryptophan depletion on mood in patients with Parkinson's disease and the healthy elderly J. Psychopharmacol. 24 2010 615 619
59. A. Mainio, K. Karvonen, H. Hakko, T. Sarkioja, and P. Rasanen Parkinson's disease and suicide: a profile of suicide victims with Parkinson's disease in a population-based study during the years 1988-2002 in Northern Finland Int. J. Geriatr. Psychiatry 24 2009 916 920
60. H. Matsui, K. Nishinaka, M. Oda, H. Niikawa, K. Komatsu, T. Kubori, and F. Udaka Depression in Parkinson's disease. Diffusion tensor imaging study J. Neurol. 254 2007 1170 1173
61. H.S. Mayberg, S.E. Starkstein, B. Sadzot, T. Preziosi, P.L. Andrezejewski, R.F. Dannals, H.N. Wagner Jr., and R.G. Robinson Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease Ann. Neurol. 28 1990 57 64
62. R. Mayeux, Y. Stern, J.B. Williams, L. Cote, A. Frantz, and I. Dyrenfurth Clinical and biochemical features of depression in Parkinson's disease Am. J. Psychiatry 143 1986 756 759
63. R. Mayeux, Y. Stern, M. Sano, J.B. Williams, and L.J. Cote The relationship of serotonin to depression in Parkinson's disease Mov. Disord. 3 1988 237 244
64. W.M. McDonald, I.H. Richard, and M.R. DeLong Prevalence, etiology, and treatment of depression in Parkinson's disease Biol. Psychiatry 54 2003 363 375
65. M.A. Menza, and M.H. Mark Parkinson's disease and depression: the relationship to disability and personality J. Neuropsychiatry Clin. Neurosci. 6 1994 165 169
66. M.A. Menza, B. Palermo, R. DiPaola, J.I. Sage, and M.H. Ricketts Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter J. Geriatr. Psychiatry Neurol. 12 1999 49 52
67. M. Menza, R.D. Dobkin, H. Marin, M.H. Mark, M. Gara, S. Buyske, K. Bienfait, and A. Dicke A controlled trial of antidepressants in patients with Parkinson disease and depression Neurology 72 2009 886 892
68. U. Merschdorf, D. Berg, I. Csoti, F. Fornadi, B. Merz, M. Naumann, G. Becker, and T. Supprian Psychopathological symptoms of depression in Parkinson's disease compared to major depression Psychopathology 36 2003 221 225
69. P.K. Morrish, J.S. Rakshi, D.L. Bailey, G.V. Sawle, and D.J. Brooks Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18 F]dopa PET J. Neurol. Neurosurg. Psychiatry 64 1998 314 319
70. R. Mossner, A. Henneberg, A. Schmitt, Y.V. Syagailo, M. Grassle, T. Hennig, R. Simantov, M. Gerlach, P. Riederer, and K.P. Lesch Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease Mol. Psychiatry 6 2001 350 352
71. B.H. Mulsant, and M. Ganguli Epidemiology and diagnosis of depression in late life J. Clin. Psychiatry 60 Suppl. 20 1999 9 15
72. T. Murai, U. Muller, K. Werheid, D. Sorger, M. Reuter, T. Becker, D.Y. von Cramon, and H. Barthel In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease J Neuropsychiatry Clin. Neurosci. 13 2001 222 228
73. M. Myslobodsky, F.M. Lalonde, and L. Hicks Are patients with Parkinson's disease suicidal? J. Geriatr. Psychiatry Neurol. 14 2001 120 124
74. S. Nazem, A.D. Siderowf, J.E. Duda, G.K. Brown, T. Ten Have, M.B. Stern, and D. Weintraub Suicidal and death ideation in Parkinson's disease Mov. Disord. 23 2008 1573 1579
75. F.M. Nilsson, L.V. Kessing, and T.G. Bolwig Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study Acta Psychiatr. Scand. 104 2001 380 386
76. M.S. Okun, and R.L. Watts Depression associated with Parkinson's disease: clinical features and treatment Neurology 58 2002 S63 S70
77. S. Palhagen, H. Qi, B. Martensson, J. Walinder, A.K. Granerus, and P. Svenningsson Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression J. Neurol. 257 2010 524 532
78. J. Parkinson An essay on the shaking palsy 1817 Sherwood, Neely, and Jones London
79. W. Paulus, and K. Jellinger The neuropathologic basis of different clinical subgroups of Parkinson's disease J. Neuropathol. Exp. Neurol. 50 1991 743 755
80. B. Ravina, J. Elm, R. Camicioli, P.G. Como, L. Marsh, J. Jankovic, and D. Weintraub The course of depressive symptoms in early Parkinson's disease Mov. Disord. 24 2009 1306 1311
81. J.S. Reijnders, U. Ehrt, W.E. Weber, D. Aarsland, and A.F. Leentjens A systematic review of prevalence studies of depression in Parkinson's disease Mov. Disord. 23 2008 183 189
82. P. Remy, M. Doder, A. Lees, N. Turjanski, and D. Brooks Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system Brain 128 2005 1314 1322
83. I.H. Richard, and R. Kurlan A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group Neurology 49 1997 1168 1170
84. I. Richard, M. McDermott, and W. McDonald A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial of Paroxetine and Venlafaxine Extended Release for Depression in Parkinson's Disease 2nd World Parkinson Congress 2010 Glasgow Scotland
85. O. Riedel, I. Heuser, J. Klotsche, R. Dodel, and H.U. Wittchen Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study J. Geriatr. Psychiatry Neurol. 23 2010 27 34
86. G. Rodin, and K. Voshart Depression in the medically ill: an overview Am. J. Psychiatry 143 1986 696 705
87. A. Rojo, M. Aguilar, M.T. Garolera, E. Cubo, I. Navas, and S. Quintana Depression in Parkinson's disease: clinical correlates and outcome Parkinsonism Relat. Disord. 10 2003 23 28
88. A. Roy, D. Pickar, M. Linnoila, A.R. Doran, P. Ninan, and S.M. Paul Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia Psychiatry Res. 15 1985 281 292
89. J. Santamaria, E. Tolosa, and A. Valles Parkinson's disease with depression: a possible subgroup of idiopathic Parkinsonism Neurology 36 1986 1130 1133
90. M. Santos, G. Gold, E. Kovari, F.R. Herrmann, V.P. Bozikas, C. Bouras, and P. Giannakopoulos Differential impact of lacunes and microvascular lesions on poststroke depression Stroke 40 2009 3557 3562
91. A. Schrag, M. Jahanshahi, and N. Quinn What contributes to quality of life in patients with Parkinson's disease? J. Neurol. Neurosurg. Psychiatry 69 2000 308 312
92. A.G. Schuurman, M. van den Akker, K.T. Ensinck, J.F. Metsemakers, J.A. Knottnerus, A.F. Leentjens, and F. Buntinx Increased risk of Parkinson's disease after depression: a retrospective cohort study Neurology 58 2002 1501 1504
93. P.J. Shah, K.P. Ebmeier, M.F. Glabus, and G.M. Goodwin Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study Br. J. Psychiatry 172 1998 527 532
94. Y.I. Sheline, P.W. Wang, M.H. Gado, J.G. Csernansky, and M.W. Vannier Hippocampal atrophy in recurrent major depression Proc. Natl. Acad. Sci. U. S. A. 93 1996 3908 3913
95. M. Shiba, J.H. Bower, D.M. Maraganore, S.K. McDonnell, B.J. Peterson, J.E. Ahlskog, D.J. Schaid, and W.A. Rocca Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study Mov. Disord. 15 2000 669 677
96. P. Skapinakis, E. Bakola, G. Salanti, G. Lewis, A.P. Kyritsis, and V. Mavreas Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials BMC Neurol. 10 2010 49
97. J.R. Slaughter, K.A. Slaughter, D. Nichols, S.E. Holmes, and M.P. Martens Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease J. Neuropsychiatry Clin. Neurosci. 13 2001 187 196
98. J.C. Soares, and J.J. Mann The functional neuroanatomy of mood disorders J. Psychiatr. Res. 31 1997 393 432
99. T. Soulas, J.M. Gurruchaga, S. Palfi, P. Cesaro, J.P. Nguyen, and G. Fenelon Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease J. Neurol. Neurosurg. Psychiatry 79 2008 952 954
100. R. Spitzer, and J.B. Williams The validity of seasonal affective disorder N. Rosenthal, M. Blehar, Seasonal affective disorders and phototherapy 1989 Guilford New-York 79 84
101. S.E. Starkstein, T.J. Preziosi, P.L. Bolduc, and R.G. Robinson Depression in Parkinson's disease J. Nerv. Ment. Dis. 178 1990 27 31
102. S.E. Starkstein, H.S. Mayberg, R. Leiguarda, T.J. Preziosi, and R.G. Robinson A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry 55 1992 377 382
103. E.N. Stenager, and E. Stenager Suicide and patients with neurologic diseases. Methodologic problems Arch. Neurol. 49 1992 1296 1303
104. E.N. Stenager, L. Wermuth, E. Stenager, and J. Boldsen Suicide in patients with Parkinson's disease. An epidemiological study Acta Psychiatr. Scand. 90 1994 70 72
105. H. Tachibana, K. Kawabata, and S. Kasama Cerebral blood flow and depression in Parkinson's disease Int. Congr. Ser. 1232 2002 599 603
106. A.E. Taylor, J.A. Saint-Cyr, A.E. Lang, and F.T. Kenny Parkinson's disease and depression. A critical re-evaluation Brain 109 1986 279 292
107. C.A. Taylor, M.H. Saint-Hilaire, L.A. Cupples, C.A. Thomas, A.E. Burchard, R.G. Feldman, and R.H. Myers Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study Am. J. Med. Genet. 88 1999 742 749
108. R.M. Torack, and J.C. Morris The association of ventral tegmental area histopathology with adult dementia Arch. Neurol. 45 1988 497 501
109. J.E. van der Heyden Epidemiology of depressive symptoms in Belgian patients suffering from Parkinson's disease: PARKIDEP 12th International Congress of Parkinson's Disease and Movement Disorders, Chicago 2008
110. V. Voon, P. Krack, A.E. Lang, A.M. Lozano, K. Dujardin, M. Schupbach, J. D'Ambrosia, S. Thobois, F. Tamma, J. Herzog, J.D. Speelman, J. Samanta, C. Kubu, H. Rossignol, Y.Y. Poon, J.A. Saint-Cyr, C. Ardouin, and E. Moro A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease Brain 131 2008 2720 2728
111. D. Weintraub, P.J. Moberg, J.E. Duda, I.R. Katz, and M.B. Stern Recognition and treatment of depression in Parkinson's disease J. Geriatr. Psychiatry Neurol. 16 2003 178 183
112. D. Weintraub, P.J. Moberg, J.E. Duda, I.R. Katz, and M.B. Stern Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease J. Am. Geriatr. Soc. 52 2004 784 788
113. D. Weintraub, K.H. Morales, P.J. Moberg, W.B. Bilker, C. Balderston, J.E. Duda, I.R. Katz, and M.B. Stern Antidepressant studies in Parkinson's disease: a review and meta-analysis Mov. Disord. 20 2005 1161 1169
114. D. Weintraub, A.B. Newberg, M.S. Cary, A.D. Siderowf, P.J. Moberg, G. Kleiner-Fisman, J.E. Duda, M.B. Stern, D. Mozley, and I.R. Katz Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease J. Nucl. Med. 46 2005 227 232
115. L. Wermuth, P.S. Sorensen, and S. Timm Depression in idiopathic Parkinson's disease treated with citalopram Nord. J. Psychiatry 52 1998 163 169
116. K. Whetten-Goldstein, F. Sloan, E. Kulas, T. Cutson, and M. Schenkman The burden of Parkinson's disease on society, family, and the individual J. Am. Geriatr. Soc. 45 1997 844 849
117. E. Wolters, and H. Braak Parkinson's disease: premotor clinico-pathological correlations J. Neural Transm. Suppl. 70 2006 309 319
118. M. Yamamoto Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background J. Neurol. 248 Suppl. 3 2001 III/5 III/11
119. J.L. Zhang, J.F. Yang, and P. Chan No association between polymorphism of serotonin transporter gene and depression in Parkinson's disease in Chinese Neurosci. Lett. 455 2009 155 158